We are live on
!
Find out more
PTC
Private Trust Company Portfolio holdings
AUM
$1.25B
1-Year Est. Return
29.12%
This Fund
S&P 500
This Quarter
Est. Return
-0.19%
1 Year Est. Return
+29.12%
3 Year Est. Return
+79.64%
5 Year Est. Return
+96.77%
10 Year Est. Return
+318.79%
AUM
$687M
AUM Growth
+$26.9M
(+4.1%)
Cap. Flow
+$32.5M
Cap. Flow
% of AUM
4.73%
Top 10 Holdings %
Top 10 Hldgs %
23.84%
Holding
409
New
12
Increased
180
Reduced
152
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.23M |
| 2 |
Amazon
AMZN
|
+$2.5M |
| 3 |
Accenture
ACN
|
+$1.87M |
| 4 |
AstraZeneca
AZN
|
+$1.66M |
| 5 |
Intuit
INTU
|
+$1.62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$2.57M |
| 2 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$772K |
| 3 |
Verizon
VZ
|
+$664K |
| 4 |
GE Aerospace
GE
|
+$596K |
| 5 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$585K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.64% |
| 2 | Healthcare | 12.73% |
| 3 | Financials | 10.11% |
| 4 | Consumer Staples | 9.52% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Amdocs
DOX
$6.5B
| $609K | 0.09% |
8,050
-191
| -2% | -$14.8K |
|
227
FTI Consulting
FCN
$4.19B
| $608K | 0.09% |
4,514
| – | – |
|
228
Idexx Laboratories
IDXX
$43.6B
| $599K | 0.09% |
963
+105
| +12% | +$70.6K |
|
229
Archer Daniels Midland
ADM
$38.6B
| $596K | 0.09% |
9,924
+1,039
| +12% | +$62.3K |
|
230
First Trust Senior Loan Fund ETF
FTSL
$2.34B
| $594K | 0.09% |
12,417
| – | – |
|
231
SS&C Technologies
SSNC
$19.5B
| $592K | 0.09% |
8,530
-173
| -2% | -$12.8K |
|
232
MSCI
MSCI
$41B
| $591K | 0.09% |
972
-1
| -0.1% | -$611 |
|
233
Centene
CNC
$32.3B
| $588K | 0.09% |
9,434
-340
| -3% | -$22.7K |
|
234
Digital Realty Trust
DLR
$71.8B
| $588K | 0.09% |
4,069
+429
| +12% | +$67.3K |
|
235
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.85B
| $587K | 0.09% |
5,563
| – | – |
|
236
GSK
GSK
$103B
| $586K | 0.09% |
12,268
-1,250
| -9% | -$62.8K |
|
237
Leidos
LDOS
$17.2B
| $586K | 0.09% |
6,097
| – | – |
|
238
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$13.9B
| $586K | 0.09% |
11,065
+2,538
| +30% | +$138K |
|
239
Texas Roadhouse
TXRH
$13.4B
| $585K | 0.09% |
6,406
-5
| -0.1% | -$467 |
|
240
Advanced Micro Devices
AMD
$785B
| $572K | 0.08% |
5,556
-381
| -6% | -$38.9K |
|
241
Ares Capital
ARCC
$14.3B
| $572K | 0.08% |
28,151
| – | – |
|
242
Constellation Brands
STZ
$23B
| $568K | 0.08% |
2,696
+654
| +32% | +$143K |
|
243
Ford
F
$55.4B
| $566K | 0.08% |
39,955
+14,590
| +58% | +$198K |
|
244
Gibraltar Industries
ROCK
$1.38B
| $559K | 0.08% |
8,020
| – | – |
|
245
Maximus
MMS
$3.09B
| $558K | 0.08% |
6,707
| – | – |
|
246
Travelers Companies
TRV
$77.4B
| $557K | 0.08% |
3,662
+568
| +18% | +$87.9K |
|
247
Forward Air
FWRD
$596M
| $552K | 0.08% |
6,647
| – | – |
|
248
Fortive
FTV
$18.2B
| $548K | 0.08% |
10,303
+205
| +2% | +$11.2K |
|
249
Dominion Energy
D
$58.8B
| $547K | 0.08% |
7,485
+980
| +15% | +$74.7K |
|
|
GRMN
250
Garmin
GRMN
$55.7B
| $547K | 0.08% |
3,516
+1,783
| +103% | +$290K |
|
Similar funds
HFM
PCM
FCCPG
SL
AC
SAM
RWM
JEST
Private Trust Company's Q3 2021 Portfolio in Review
As of Q3 2021, Private Trust Company held 409 positions worth $687M, up 4.1% from $660M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Private Trust Company deployed $32.5M of net new capital in Q3 2021, opening 12 new positions and adding to 180 existing holdings. Its largest new stake was Fastenal: 42,488 shares worth $1.1M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $772K trimmed.
- Private Trust Company's largest Q3 2021 buy was Fastenal: 42,488 shares worth $1.1M.
- Private Trust Company added most to Apple in Q3 2021, an estimated $4.23M increase.
- Private Trust Company's biggest Q3 2021 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $772K.
- Private Trust Company fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $2.57M.
- Private Trust Company's ten largest holdings make up 24% of its $687M portfolio in Q3 2021.
- Private Trust Company opened 12 new positions and closed 12 in Q3 2021.
- Private Trust Company's portfolio value rose 4.1% quarter-over-quarter to $687M.
Based on Private Trust Company's 13F filing for Q3 2021, filed 6 Oct 2021.